These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
677 related articles for article (PubMed ID: 35185897)
1. A Signature of N Chen J; Lu T; Zhong F; Lv Q; Fang M; Tu Z; Ji Y; Li J; Gong X Front Immunol; 2022; 13():809872. PubMed ID: 35185897 [TBL] [Abstract][Full Text] [Related]
2. Construction of an m6A-related lncRNA pair prognostic signature and prediction of the immune landscape in head and neck squamous cell carcinoma. Zhou C; Wang S; Shen Z; Shen Y; Li Q; Shen Y; Huang J; Deng H; Ye D; Zhan G; Li J J Clin Lab Anal; 2022 Jan; 36(1):e24113. PubMed ID: 34783061 [TBL] [Abstract][Full Text] [Related]
3. Development and validation of a fourteen- innate immunity-related gene pairs signature for predicting prognosis head and neck squamous cell carcinoma. Zhang F; Liu Y; Yang Y; Yang K BMC Cancer; 2020 Oct; 20(1):1015. PubMed ID: 33081731 [TBL] [Abstract][Full Text] [Related]
4. A pyroptosis-related lncRNA signature predicts prognosis and immune microenvironment in head and neck squamous cell carcinoma. Zhu W; Ye Z; Chen L; Liang H; Cai Q Int Immunopharmacol; 2021 Dec; 101(Pt B):108268. PubMed ID: 34688154 [TBL] [Abstract][Full Text] [Related]
5. Development of Chromatin Regulator-related Molecular Subtypes and a Signature to Predict Prognosis and Immunotherapeutic Response in Head and Neck Squamous Cell Carcinoma. Huang J; Xu Z; Wang Z; Zhou C; Shen Y Curr Cancer Drug Targets; 2024; 24(8):804-819. PubMed ID: 38310463 [TBL] [Abstract][Full Text] [Related]
6. Identification of Immune-Related Prognostic Biomarkers Associated with HPV-Positive Head and Neck Squamous Cell Carcinoma. Chen Y; Nie J; Li X; Fan T; Deng X; Liang D; Song G J Immunol Res; 2021; 2021():6661625. PubMed ID: 33506058 [TBL] [Abstract][Full Text] [Related]
7. Identification and validation of a novel risk model based on cuproptosis‑associated m6A for head and neck squamous cell carcinoma. Xing Z; Xu Y; Xu X; Yang K; Qin S; Jiao Y; Wang L BMC Med Genomics; 2024 May; 17(1):137. PubMed ID: 38778403 [TBL] [Abstract][Full Text] [Related]
8. Identification of m6A methyltransferase-related genes predicts prognosis and immune infiltrates in head and neck squamous cell carcinoma. Zhang Y; Li L; Ye Z; Zhang L; Yao N; Gai L Ann Transl Med; 2021 Oct; 9(20):1554. PubMed ID: 34790760 [TBL] [Abstract][Full Text] [Related]
9. m6A RNA methylation regulator-related signatures exhibit good prognosis prediction ability for head and neck squamous cell carcinoma. Zhai Y; Zheng L Sci Rep; 2022 Sep; 12(1):16358. PubMed ID: 36175504 [TBL] [Abstract][Full Text] [Related]
10. Development and validation of a novel ferroptosis-related gene signature for predicting prognosis and immune microenvironment in head and neck squamous cell carcinoma. He F; Chen Z; Deng W; Zhan T; Huang X; Zheng Y; Yang H Int Immunopharmacol; 2021 Sep; 98():107789. PubMed ID: 34130150 [TBL] [Abstract][Full Text] [Related]
11. Identification of an individualized therapy prognostic signature for head and neck squamous cell carcinoma. Lin C; Chen Y; Pan J; Lu Q; Ji P; Lin S; Liu C; Lin S; Li M; Zong J BMC Genomics; 2023 Apr; 24(1):221. PubMed ID: 37106442 [TBL] [Abstract][Full Text] [Related]
12. Identification of pyroptosis-related gene prognostic signature in head and neck squamous cell carcinoma. Li Z; Shen L; Li Y; Shen L; Li N Cancer Med; 2022 Dec; 11(24):5129-5144. PubMed ID: 35574984 [TBL] [Abstract][Full Text] [Related]
13. A composite score based on immune-related gene prognostic index and m Yang Y; Cai Z; Huang K; Li M; Wang X; Lin Y; Chen S; Yang Z; Lin Z Front Genet; 2023; 14():1061569. PubMed ID: 36845378 [No Abstract] [Full Text] [Related]
14. Tumor Mutation Burden, Immune Cell Infiltration, and Construction of Immune-Related Genes Prognostic Model in Head and Neck Cancer. Jiang AM; Ren MD; Liu N; Gao H; Wang JJ; Zheng XQ; Fu X; Liang X; Ruan ZP; Tian T; Yao Y Int J Med Sci; 2021; 18(1):226-238. PubMed ID: 33390791 [No Abstract] [Full Text] [Related]
15. A model of seven immune checkpoint-related genes predicting overall survival for head and neck squamous cell carcinoma. Song D; Tian J; Han X; Li X Eur Arch Otorhinolaryngol; 2021 Sep; 278(9):3467-3477. PubMed ID: 33449165 [TBL] [Abstract][Full Text] [Related]
16. Ubiquitination-Related Gene Signature, Nomogram and Immune Features for Prognostic Prediction in Patients with Head and Neck Squamous Cell Carcinoma. Yang H; Zhou L; Shi M; Yu J; Xie Y; Sun Y Genes (Basel); 2024 Jul; 15(7):. PubMed ID: 39062659 [TBL] [Abstract][Full Text] [Related]
18. The prognostic value of m6A-related LncRNAs in patients with HNSCC: bioinformatics analysis of TCGA database. Zhou LQ; Shen JX; Zhou JY; Hu Y; Xiao HJ Sci Rep; 2022 Jan; 12(1):579. PubMed ID: 35022464 [TBL] [Abstract][Full Text] [Related]
19. A novel immune-related long non-coding RNA signature improves the prognosis prediction in the context of head and neck squamous cell carcinoma. Chen L; Cai Z; Lyu K; Cai Z; Lei W Bioengineered; 2021 Dec; 12(1):2311-2325. PubMed ID: 34167440 [TBL] [Abstract][Full Text] [Related]
20. Hypoxia-related signature to risk stratify patients for the benefit of immune checkpoint inhibitors therapy in head and neck squamous cell carcinoma: An experimental study. Zhao Y; Yang Z; Fu M; Wu S; Wang M; Li J; Wang Z; Li W Medicine (Baltimore); 2024 Aug; 103(31):e39184. PubMed ID: 39093745 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]